Wells Fargo & Company Caribou Biosciences, Inc. Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 41,607 shares of CRBU stock, worth $77,805. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,607
Previous 35,301
17.86%
Holding current value
$77,805
Previous $181,000
62.43%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CRBU
# of Institutions
144Shares Held
53.7MCall Options Held
32.5KPut Options Held
89.8K-
Black Rock Inc. New York, NY6.95MShares$13 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$8.5 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.16MShares$7.78 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA4.08MShares$7.64 Million0.34% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.62MShares$4.91 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $114M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...